Sarepta CEO Doug Ingram said it is important the company maintains a “positive working relationship” with the FDA.

World shares were mixed on Tuesday after US stock indexes inched to more records at the start of a week of profit updates ...

Asian markets are mixed after U.S. stock indexes hit new records on Monday. Oil prices fell and U.S. futures were little ...

Sarepta Therapeutics shares were lower in premarket trading on Tuesday, as the drugmaker relented to a Food and Drug ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...